OpenAlex
PricingAboutJobs
Log inGet started
Work

Alendronate Is a Specific, Nanomolar Inhibitor of Farnesyl Diphosphate Synthase

HTML

Year: 2000
Type: article
Source: Archives of Biochemistry and Biophysics
DOI: 10.1006/abbi.1999.1502
Authors: James D. Bergstrom, Richard G. Bostedor, Patricia J. Masarachia, Alfred A. Reszka, Gideon Rodan
Institution: Merck & Co., Inc., Rahway, NJ, USA (United States)
Language: English

Topic: Bone health and treatments
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Keywords: alendronate, farnesyl diphosphate synthase, bisphosphonates, mevalonate pathway, protein prenylation, isoprenoid biosynthesis, geranylgeranyl diphosphate, isopentenyl diphosphate isomerase, pamidronate, risedronate, etidronate, clodronate, osteoclasts, sterol biosynthesis, enzyme inhibition, osteoporosis treatment
SDG: Good health and well-being

Open Access status: closed
OpenAlex ID: W2076107807
FWCI: 15.42
Cites: 31
Cited by: 443
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms